More on BNTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $106.43 |
|
|||
| Open | $106.09 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $106.69 | ||||
| Day Low | $104.64 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 470,573 | ||||
- BioNTech SE (BNTX) call put ratio 1 call to 1 put as share price down 3.5%
- Moderna (MRNA) declines on concerns about takeup of Covid booster
- BioNTech SE (BNTX) September call option implied volatility flat
- Form 6-K BioNTech SE For: Sep 11
- BioNTech SE (BNTX) option IV after FDA announces approval for 2023-2024 COVID-19 vaccine
- Pfizer (PFE) and BioNTech (BNTX) Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
- Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
- Form 6-K BioNTech SE For: Aug 30
- Pfizer And Biontech Receive Positive CHMP Opinion For Omicron Xbb.1.5-adapted Covid-19 Vaccine In The EU - Reuters
- COVID-19 vaccine stocks gain as Biden expected to request new vaccine, recommended for all
Entities mentioned with BNTX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- AdCom | View Related Stories »
- Definitive Agreement | View Related Stories »
- Pre Market Movers | View Related Stories »
- JPMorgan | View Related Stories »
- Options | View Related Stories »
- Show More...
